how were glp 1 agonists discovered History of glucagon-like peptide-1 receptor how do glp 1 agonists

We used R version 4.2.2 (R Foundation for Statistical Computing, Vienna, Austria) along with the packages metafor and meta to carry out the analyses

Between 1969 and 1971, work by John Brown and Raymond Pederson, together with the peptide chemistry expertise of Erik Jorpes and Viktor Mutt [67], led to the identification of the gastric inhibitory polypeptide (GIP), a 42-amino acid polypeptide that was named based on its potency to suppress gastric motility and gastric acid secretion [[68], [69], [70]]

GlaxoSmithKline GLP-1 Tanzeum meets its end, and it doesnt bode well for Sanofi, AstraZeneca: analyst , (Jul 31, 2017)

The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem

As governments and insurers recognize the economic and healthcare burden of obesity, coverage and accessibility are set to improve, further accelerating market adoption

77 Overall, GLP-1 RAs appear more relevant in HFpEF, particularly with concomitant obesity, where BP lowering contributes to broader cardiometabolic benefits rather than a direct heart failure therapy